SkinHealth Systems SKIN
NASDAQ SKIN
$0.74 +0.05 (+7.61%)
At close: Sep 8, 2026 · 4:00 PM EDT

SkinHealth Systems (SKIN) Non-Current Debt (2020)

SkinHealth Systems' (SKIN) quarterly Non-Current Debt came in at $216.0 million in Q4 2020.

Analysis

SkinHealth Systems (SKIN) Non-Current Debt (2020) Analysis & Trends

SkinHealth Systems (SKIN) has reported Non-Current Debt for 1 consecutive years, with $216.0 million the latest figure, recorded in Q4 2020.

  • On a quarterly basis, Non-Current Debt changed N/A year-over-year to $216.0 million in Q4 2020; TTM through Dec 2020 was $216.0 million, a N/A change from a year earlier, with the FY2020 full-year figure at $216.0 million, changed N/A from the prior year.
  • Non-Current Debt was $216.0 million for Q4 2020 at SkinHealth Systems.
  • Over five years, Non-Current Debt peaked at $216.0 million in Q4 2020 and troughed at $216.0 million in Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 29.60 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 25.62 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 14.19 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 10.92 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 598.70 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -1.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 1.65 Bn
10 SkinHealth Systems 89.77 Mn -116.30 Mn 49.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 216.02 Mn